Liposomal amphotericin B treatment of cutaneous leishmaniasis due to Leishmania tropica.

Volume: 25, Issue: 8, Pages: 973 - 977
Published: Aug 1, 2011
Abstract
Background  Cutaneous leishmaniasis (CL) is endemic in Israel, and in the past, has been attributed almost exclusively to Leishmania major. Over the last decade or so, an increase in Leishmania tropica (L. tropica) infections has occurred in several regions of Israel. Topical treatment of Old World CL is usually the rule, however, in some cases systemic treatment is indicated. Liposomal amphotericin B (L-AmB) is efficacious and safe for treating...
Paper Fields
Paper Details
Title
Liposomal amphotericin B treatment of cutaneous leishmaniasis due to Leishmania tropica.
Published Date
Aug 1, 2011
Volume
25
Issue
8
Pages
973 - 977
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.